Provided by Tiger Trade Technology Pte. Ltd.

Biomea Fusion, Inc.

1.22
+0.03002.52%
Post-market: 1.20-0.0193-1.58%19:59 EST
Volume:4.95M
Turnover:6.36M
Market Cap:86.26M
PE:-0.55
High:1.46
Open:1.37
Low:1.19
Close:1.19
52wk High:6.57
52wk Low:0.8719
Shares:70.70M
Float Shares:57.24M
Volume Ratio:3.78
T/O Rate:8.65%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.2050
EPS(LYR):-3.8339
ROE:-209.00%
ROA:-75.23%
PB:5.52
PE(LYR):-0.32

Loading ...

BUZZ-U.S. STOCKS ON THE MOVE-Omnicom, Albemarle, energy companies

Reuters
·
Yesterday

BUZZ-U.S. STOCKS ON THE MOVE-Warner Bros Discovery, Ulta Beauty, Victoria's Secret

Reuters
·
Dec 05

BUZZ-Biomea Fusion rises as diabetes drug shows promise

Reuters
·
Dec 05

Biomea Fusion Reports Durable Glycemic Improvements with Icovamenib in Type 2 Diabetes Trial

Reuters
·
Dec 05

Biomea Fusion Presents Covalent-111 Study Results at the 23Rd World Congress on Insulin Resistance, Diabetes & Cardiovascular Disease (Wcirdc)

THOMSON REUTERS
·
Dec 05

Interim CEO Michael J.M. Hitchcock Reports Acquisition of Biomea Fusion Inc. Common Shares

Reuters
·
Dec 05

Biomea Fusion Inc. CEO and Director Rainer M. Erdtmann Reports Acquisition of Common Shares

Reuters
·
Dec 03

Biomea Fusion Unveils Positive Long-Term Icovamenib Data in Type 2 Diabetes at WCIRDC

Reuters
·
Dec 02

Biomea Fusion Announces Oral Presentation of Icovamenib at the 23Rd World Congress on Insulin Resistance, Diabetes & Cardiovascular Disease (Wcirdc)

THOMSON REUTERS
·
Dec 02

Biomea Fusion Grants Stock Options to New Employee Under 2023 Inducement Plan

Reuters
·
Dec 02

Biomea Fusion, Inc. Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
Dec 02

Biomea Fusion to Join Piper Sandler and Evercore Healthcare Investor Conferences

Reuters
·
Nov 24

JPMorgan Downgrades Biomea Fusion to Underweight From Neutral

MT Newswires Live
·
Nov 17

U.S. RESEARCH ROUNDUP- Applied Materials, Blackstone Mortgage, Brookdale Senior Living

Reuters
·
Nov 17

Biomea Fusion Inc : JP Morgan Cuts to Underweight From Neutral

THOMSON REUTERS
·
Nov 17

Biomea Fusion downgraded to Underweight from Neutral at JPMorgan

TIPRANKS
·
Nov 15

Biomea Fusion Is Maintained at Buy by Citigroup

Dow Jones
·
Nov 11

Biomea Fusion Inc. to Present at Jefferies London Healthcare Conference

Reuters
·
Nov 10

Biomea Fusion Is Maintained at Buy by D. Boral Capital

Dow Jones
·
Nov 05

Biomea Fusion Launches Phase I Trial of Oral GLP-1 Agonist BMF-650 for Obesity

Reuters
·
Nov 05